CYVADE Trademark

Trademark Overview


On Friday, August 23, 2002, a trademark application was filed for CYVADE with the United States Patent and Trademark Office. The USPTO has given the CYVADE trademark a serial number of 76443323. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Saturday, March 31, 2007. This trademark is owned by Eli Lilly and Company. The CYVADE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of cancer, central nervous systems diseases and disorders, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, , urological disorders
cyvade

General Information


Serial Number76443323
Word MarkCYVADE
Filing DateFriday, August 23, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSaturday, March 31, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 7, 2003

Trademark Statements


Goods and Servicespharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of cancer, central nervous systems diseases and disorders, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, , urological disorders
Translation of Words in MarkThe mark "CYVADE" is a coined, non-dictionary, non-foreign word with no English translation.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 13, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Wednesday, June 20, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, June 20, 2007ABANDONMENT - NO USE STATEMENT FILED
Friday, September 1, 2006EXTENSION 5 GRANTED
Monday, July 31, 2006EXTENSION 5 FILED
Monday, July 31, 2006TEAS EXTENSION RECEIVED
Friday, February 17, 2006EXTENSION 4 GRANTED
Friday, January 27, 2006EXTENSION 4 FILED
Friday, January 27, 2006TEAS EXTENSION RECEIVED
Wednesday, September 21, 2005EXTENSION 3 GRANTED
Tuesday, August 30, 2005EXTENSION 3 FILED
Tuesday, August 30, 2005TEAS EXTENSION RECEIVED
Tuesday, February 15, 2005EXTENSION 2 GRANTED
Tuesday, February 1, 2005EXTENSION 2 FILED
Tuesday, February 1, 2005TEAS EXTENSION RECEIVED
Tuesday, September 7, 2004EXTENSION 1 GRANTED
Tuesday, August 24, 2004EXTENSION 1 FILED
Tuesday, August 24, 2004TEAS EXTENSION RECEIVED
Monday, June 21, 2004CASE FILE IN TICRS
Tuesday, March 30, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 12, 2003EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 7, 2003PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2002NOTICE OF PUBLICATION
Saturday, November 2, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 2, 2002ASSIGNED TO EXAMINER